Capital Advantage »

Eli Lilly & Co. shares owned by Capital Advantage

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Capital Advantage from 13F filings

Historical chart of Capital Advantage investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Capital Advantage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Capital Advantage

Quarter filed Position value Share count Share price at filing
2025-09-30 $458k 600 763.30
2025-06-30 $468k 600 779.38
2025-03-31 $441k 571 772.31
2024-12-31 $441k 571 772.31

More positions owned by Capital Advantage

Vanguard Scottsdale Fds Int-term Corp (VCIT)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Select Sector Spdr Tr Financial (XLF)
Vanguard World Health Car Etf (VHT)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Spdr Series Trust Portfolio S&p500 (SPLG)
Vanguard World Industrial Etf (VIS)
Vanguard World Mega Cap Index (MGC)
Apple (AAPL)

View all positions for Capital Advantage

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Morgan Stanley
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3

View all funds holding Eli Lilly & Co.